MAPT and Alzheimer disease: This reduction in Ran expression and reduced nucleocytoplasmic transport has also been observed in an earlier study using Alzheimer’s disease brain samples and neuroblastoma cells,109 suggesting that nucleocytoplasmic transport deficits may directly contribute to tau pathology and disease progression.